Beta-Carotene and Macular Degeneration Prevention Study

Macular degeneration is a leading cause of blindness, especially in people aged 65 and older in the United States. This condition affects over 100,000 people each year, with no known prevention methods or treatments for most patients. The cause of macular degeneration remains unclear, but research suggests that antioxidants like beta-carotene might play a protective role. This study is part of the Physicians Health Study, sponsored by the National Heart, Lung, and Blood Institute, and focuses on exploring the potential of beta-carotene in preventing macular degeneration. The trial involves over 22,000 physicians who are randomly assigned to take either beta-carotene or a placebo. In this trial, participants take one 50-mg beta-carotene capsule every other day. The study measures the effectiveness of beta-carotene by comparing the occurrence of macular degeneration between the group taking beta-carotene and the group taking a placebo. Any reported diagnoses of macular degeneration are confirmed through medical record reviews. The Cox proportional hazards model is used to determine whether there is a difference in time to diagnosis of macular degeneration between the two groups. This study aims to shed light on the potential protective role of beta-carotene in preventing macular degeneration and to identify any additional risk factors.